HCW Biologics News - June 26, 2026
HCWB's Second Reverse Split in 14 Months: Can a Clinical-Stage Biotech Survive on Financial Engineering Alone?
Shares of HCW Biologics dropped 15.2% to $0.95 after the company announced its board approved a 1-for-6 reverse stock split, effective June 30, 2026 — the...
🔴 HCWB is trading 15% down today after announcing a 1-for-6 reverse split for Nasdaq compliance
HCWB is trading 15% down at $0.95 after its Board approved a 1-for-6 reverse stock split aimed at maintaining compliance with Nasdaq’s $1.00 minimum bid price...
HCW Biologics Announces 1-for-6 Reverse Stock Split to Maintain Nasdaq Listing
HCW Biologics Inc. (HCWB) announced its Board of Directors has approved a 1-for-6 reverse stock split of its common stock, effective June 30, 2026. This action...
🔴 HCWB Plunges 23.9% After Announcing 1-for-6 Reverse Stock Split
HCWB is trading at $0.85 (23.9% down) after HCW Biologics announced a 1-for-6 reverse stock split of its common stock, effective June 30, 2026. • The reverse...
🟢 HCWB is trading 5.5% up today as rebound above Nasdaq minimum bid level continues
HCWB is trading at $1.18 (5.5% up) in pre-market as the stock extends a recent rebound that has taken shares back above the Nasdaq $1.00 minimum bid...